Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2005
03/31/2005WO2005000897A3 Antibodies against interleukin-22 and uses therefor
03/31/2005WO2004112829A3 Compositions and methods for the diagnosis and treatment of tumors of glial origin
03/31/2005WO2004106532A8 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b
03/31/2005WO2004087876A3 Use of red blood cells to facilitate cell activation
03/31/2005WO2004087744A3 Composition and method for nerve regeneration
03/31/2005WO2004087736A3 Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip)
03/31/2005WO2004087062A3 Compositions and methods involving respiratory syncytial virus subgroup b strain 9320
03/31/2005WO2004085476A3 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
03/31/2005WO2004080579A3 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
03/31/2005WO2004076677A3 Monoclonal antibody production by ebv transformation of b cells
03/31/2005WO2004075839A3 Methods and compositions for modulating apoptosis
03/31/2005WO2004075838A3 Method and compositions for the treatment of meconium aspiration syndrome
03/31/2005WO2004073499A3 Diagnosis of primary open angle glaucoma
03/31/2005WO2004063351A3 IDENTIFICATION AND ENGINEERING OF ANTIBODIES WITH VARIANT Fc REGIONS AND METHODS OF USING SAME
03/31/2005WO2004045526A3 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
03/31/2005WO2004043233A3 Assay for autoantibodies to folate receptors
03/31/2005WO2004039234A3 Humanized antibodies against the venezuelan equine encephalitis virus
03/31/2005WO2004010951A8 Method of treating tumors
03/31/2005WO2003096877A3 Prevention and treatment of streptococcal and staphylococcal infection
03/31/2005WO2003092597A3 Antibodies that specifically bind to chemokine beta-4
03/31/2005WO2003040329A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/31/2005US20050071894 Nonhuman model animal lacking the ability to control lymphocyte migration
03/31/2005US20050070700 Equine arteritis virus vaccine
03/31/2005US20050070699 Nucleotide sequences coding low density lipoprotein receptor-related protein 5 for use as tools in diagnosis and treatment of osteoporosis; high bone mass and bone disorders
03/31/2005US20050070694 Antagonistic anti-htnfsf13b human antibodies
03/31/2005US20050070693 Chimeric monoclonal antibody specific to leukocyte receptor for use as tool in treatment and prevention of cell proliferative, autoimmune, prion, liver and inflammatory disorders; immunotherapy
03/31/2005US20050070692 Anti-interleukin-1 beta analogs
03/31/2005US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders
03/31/2005US20050070495 Inhibition of DNA modulation caused by mutated p53
03/31/2005US20050070461 Means and methods for altering the motility of the gastrointestinal tract
03/31/2005US20050070002 Histidine phosphatase interacting protein with 120kd
03/31/2005US20050069984 Identification of sortase gene
03/31/2005US20050069983 Nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatment of herpes viral infection, cell proliferative and autoimmune disorders
03/31/2005US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents
03/31/2005US20050069968 Sampling cerebrospinal fluid for antibodies; solid phase synthesis; immunoassay
03/31/2005US20050069966 Using gastrin concentration as diagnostic tool in detetction and treatment of gastrointestinal disorders
03/31/2005US20050069964 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC)
03/31/2005US20050069955 Fragment or antibody comprising consensus sequence hexapeptide; anticarcinogenic, antitumor, antimetastasis, and antiinflammatory agents; autoimmune and cardiovascular disorders; leukemia; library of immunoglobulin binding domains having a diverse antigen-binding domain for complementary binding
03/31/2005US20050069947 Antibodies specific for nanotubes and related methods and compositions
03/31/2005US20050069946 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer
03/31/2005US20050069943 101 human secreted proteins
03/31/2005US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter
03/31/2005US20050069931 Non-invasive diagnostic test utilizing histone modification markers
03/31/2005US20050069914 Novel glycoproteins and methods of use thereof
03/31/2005US20050069896 Rb pathway and chromatin remodeling genes that antagonize let-60 Ras signaling
03/31/2005US20050069888 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof
03/31/2005US20050069878 Proteins associated with cell growth, differentiation, and death
03/31/2005US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
03/31/2005US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders.
03/31/2005US20050069869 Nucleotide sequences coding severe acute respiratory syndrome (SARS) spike glycoprotein for use as tool in development of immunoglobulins for prevention and treatment of respiratory system disorders; immunotherapy; imunodiagnostics
03/31/2005US20050069865 Synthetic hcv envelope proteins and their use for vaccination
03/31/2005US20050069561 vaccine against Newcastle Disease contains one or more mutant immunogens of the NDW strain that lack the antigenic binding site on the F glycoprotein which is recognized by the monoclonal antibody mAb 54.
03/31/2005US20050069556 Serology display library; analyzing autologous tumor antigen; drug design; antitumor vaccine containing antigen
03/31/2005US20050069554 Genetic engineered vitaxin monoclonal antibodies; prevention therapy of angiogenesis, restenosis
03/31/2005US20050069552 Heavy and light chain peptides; generating antibody genes; binding to antigens
03/31/2005US20050069549 Targeted ligands
03/31/2005US20050069547 Binding protein; therapy for bone tumors
03/31/2005US20050069545 Diagnosis, therapy od autoimmune disease
03/31/2005US20050069543 Antibody mixture; immunosuppressant ; antitumor agents
03/31/2005US20050069542 Antibodies that specifically bind to GMAD
03/31/2005US20050069540 Treating b-cell mediated diseases by modulating dr6 activity
03/31/2005US20050069539 Anticancer agents; genetic engineering; monoclonal antibodies
03/31/2005US20050069538 Therapeutic binding molecules
03/31/2005US20050069536 Contacting male ejaculate, prior to contact with a female egg, with an effective anti-fertility amount of a pharmaceutical composition, which comprises an antibody that binds a surface exposed epitope of SP22, and a pharmaceutically acceptable carrier
03/31/2005US20050069535 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
03/31/2005CA2540138A1 Recombinant antibody against human insulin-like growth factor
03/31/2005CA2540133A1 Drugs for treating cancer
03/31/2005CA2539789A1 Peptide originating in hepatitis c virus
03/31/2005CA2539562A1 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity
03/31/2005CA2539437A1 Peptide that binds to a broadly neutralizing anti-hiv antibody-structure of 4e10 fab fragment complex, uses thereof, compositions therefrom
03/31/2005CA2539322A1 Kid3 and kid3 antibodies that bind thereto
03/31/2005CA2539270A1 Immunogen
03/31/2005CA2539172A1 High-yield method for the production of human antibodies blocking the biological activity of a human cytokine
03/31/2005CA2539116A1 Cripto antagonism of activin and tgf-b signaling
03/31/2005CA2539065A1 Coumpounds for neutralising the effects of secreted pla2 iia
03/31/2005CA2539061A1 Use of an antagonist of il-6 for treating il-6-mediated diseases
03/31/2005CA2538887A1 Measles subunit vaccine
03/31/2005CA2538284A1 Modulators of p-selectin glycoprotein ligand 1
03/31/2005CA2534959A1 Antibodies with altered effector functions
03/31/2005CA2520853A1 Anti-amyloid antibodies, compositions, methods and uses
03/30/2005WO2005033704A1 Immunoassay
03/30/2005EP1519193A2 Methods for detecting cancers expressing vascular endothelial growth factor D
03/30/2005EP1519192A2 HIV Protease inhibitor conjugates and antibodies useful in ummunoassay
03/30/2005EP1518926A1 HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT
03/30/2005EP1518864A2 Antibody against rhesus D
03/30/2005EP1518863A1 Antibodies modulating the activity of equine chorionic gonadotropin.
03/30/2005EP1517998A2 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
03/30/2005EP1517923A2 Compositions and methods for inhibiting microbial adhesion
03/30/2005EP1517922A2 Preparation based on an antibody directed against a tumor-associated glycosylation such as lewis structures
03/30/2005EP1517921A2 Immunoglobulin single variable antigen-binding domains and dual-specific constructs thereof
03/30/2005EP1517920A2 Product
03/30/2005EP1517917A2 Human erg2 potassium channel
03/30/2005EP1517724A2 Anti-angiogenic proteins and fragmentsand methods of use thereof
03/30/2005EP1517704A1 Use of antibodies against flt-1 for the treatment of osteoporosis
03/30/2005EP1517703A1 Placental growth factor as a target for the treatment of osteoporosis
03/30/2005EP1517700A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/30/2005EP1517606A2 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
03/30/2005EP1224298B1 Fibrinolytically active polypeptide
03/30/2005EP1185867B1 Method for separating cells using immunorosettes
03/30/2005EP1124570A4 Novel neuropilin/growth factor binding and uses thereof
1 ... 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 ... 1494